Main competitors
P/E (Y) Price to Book (Y) PEG (Y) EV / Sales (Y) EV / EBITDA (Y) EV / EBIT (Y) Dividend Yield (Y) Capi.($)
-9.23x4.3x-0.24x4.13x-7.63x-7.16x-.--% 2.3B
17.46x1.99x-2.11x3.77x9.89x11.29x0.59% 67.6B
25.31x3.82x1.86x5.22x15.34x19.02x0.62% 51.32B
34.21x6.88x0.66x11.6x22.16x25.82x-.--% 42.97B
-45.86x2.5x0.35x3.23x9.53x11.12x3.35% 40.81B
23.43x1.56x-5.52x3.44x11.52x13.06x-.--% 29.12B
-7.88x4.78x-0.41x11.31x-6.95x-6.52x-.--% 27.09B
41.12x - -0.73x - - - -.--% 22.99B
70.11x6.3x0.45x6.96x47.88x54.02x-.--% 21.55B
25.32x3.56x0.02x5.23x14.01x19.32x-.--% 16.38B
-37.67x-6.59x0.9x17.6x-53.43x-55.86x-.--% 16.2B
-115.14x12581.04x2.62x12.37x-88.58x-123.51x-.--% 12.22B
16.74x - 0.17x3.57x13.08x15.67x-.--% 11.39B
52.78x21.52x0.5x31.9x45.12x46.53x0.18% 10.37B
46.21x - 4.28x - - - -.--% 10.32B
74.98x5.3x-0.96x - - - - 7.12B
11.86x1.03x0.41x1.8x7.28x9.76x2.83% 6.22B
30x - 1.47x8.1x21.49x25.66x0.34% 6.13B
14.4x1.32x-0.21x2.55x6.6x7.99x1.57% 5.79B
-45.76x - -0.82x - - - - 5.77B
Average 11.12x 842.62x 0.13x 8.30x 4.21x 4.14x 0.53% 20.68B
Weighted average by Cap. 12.58x 434.25x -0.21x 7.31x 8.36x 9.47x 0.6%
Biopharmaceuticals